FERMENTA BIOTECH LTD. Share Price
FERMENTA BIOTECH LTD. Share Price Today
As of 5 Jul 2026, FERMENTA BIOTECH LTD. share price is ₹343.00. The stock opened at ₹351.95, compared to its previous close of ₹352.00. During today's trading session, FERMENTA BIOTECH LTD. share price moved in the range of ₹336.80 to ₹356.80, with an average price of ₹346.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹248.85 and a high of ₹375.95. On the performance front, FERMENTA BIOTECH LTD. share price has increased by 9.87% over the last six months and is up 9.87% on a year-on-year basis.
FERMENTA BIOTECH LTD. Returns Calculator
FERMENTA BIOTECH LTD. Shareholder Returns
FERMENTA BIOTECH LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
FERMENTA BIOTECH LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹469.48 | ₹335.66 | ₹349.94 | ₹398.52 |
| Other Income | ₹11.82 | ₹11.81 | ₹8.60 | ₹8.14 |
| Total Revenue | ₹481.30 | ₹347.47 | ₹358.54 | ₹406.65 |
| Total Expenses | ₹398.09 | ₹349.92 | ₹381.37 | ₹379.71 |
| Profit Before Tax | ₹83.21 | -₹9.87 | -₹51.31 | ₹26.94 |
| Tax | ₹6.81 | ₹14.14 | ₹1.83 | ₹11.88 |
| Profit After Tax | ₹76.40 | -₹24.01 | -₹53.13 | ₹15.06 |
| EPS - Basic | ₹26.35 | -₹7.99 | -₹17.70 | ₹5.35 |
| EPS - Diluted | ₹26.35 | -₹7.99 | -₹17.70 | ₹5.35 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹83.21 | -₹9.87 | -₹51.31 | ₹26.94 |
| Income before WC changes | ₹126.17 | ₹71.62 | ₹67.95 | ₹70.13 |
| Change in Assets | -₹95.24 | ₹13.24 | ₹42.94 | -₹20.07 |
| Change in Liabilities | ₹12.74 | ₹19.46 | ₹2.01 | ₹2.69 |
| Change in WC | -₹82.50 | ₹32.70 | ₹44.95 | -₹17.38 |
| Cash flow from Operations | ₹40.90 | ₹105.35 | ₹116.11 | ₹43.44 |
| Cash flow from Investing | -₹0.16 | -₹15.50 | -₹55.41 | -₹26.04 |
| Cash flow from Financing | -₹50.87 | -₹90.85 | -₹41.38 | -₹21.58 |
| Total Cash Flow | -₹10.12 | -₹1.00 | ₹19.32 | -₹4.17 |
| Cash (Start of the year) | ₹16.75 | ₹17.75 | -₹1.61 | ₹2.29 |
| Cash (End of the year) | ₹6.63 | ₹16.75 | ₹17.75 | -₹1.88 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹279.24 | ₹306.08 | ₹383.49 | ₹392.82 |
| Current Assets | ₹335.23 | ₹241.75 | ₹253.02 | ₹314.02 |
| Total Assets | ₹614.48 | ₹547.83 | ₹636.52 | ₹706.84 |
| Current Liabilities | ₹211.88 | ₹173.26 | ₹208.72 | ₹207.12 |
| Net Current Asset | ₹123.36 | ₹68.49 | ₹44.31 | ₹106.90 |
| Non-Current Liabilities | ₹44.08 | ₹89.41 | ₹115.23 | ₹128.27 |
| Equity Capital | ₹358.52 | ₹285.16 | ₹312.56 | ₹371.45 |
| Total Equity & Liabilities | ₹614.48 | ₹547.83 | ₹636.52 | ₹706.84 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹430.53 | ₹307.09 | ₹328.91 | ₹387.96 |
| Other Income | ₹11.68 | ₹8.15 | ₹8.46 | ₹7.53 |
| Total Revenue | ₹442.21 | ₹315.24 | ₹337.38 | ₹395.49 |
| Total Expenses | ₹367.79 | ₹310.85 | ₹335.76 | ₹352.92 |
| Profit Before Tax | ₹74.42 | -₹4.61 | -₹57.98 | ₹42.56 |
| Tax | ₹6.81 | ₹14.14 | -₹0.97 | ₹12.33 |
| Profit After Tax | ₹67.62 | -₹18.74 | -₹57.00 | ₹30.24 |
| EPS - Basic | ₹23.18 | -₹6.49 | -₹19.75 | ₹10.48 |
| EPS - Diluted | ₹23.18 | -₹6.49 | -₹19.75 | ₹10.48 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹74.42 | -₹4.61 | -₹57.98 | ₹42.56 |
| Income before WC changes | ₹114.74 | ₹80.82 | ₹88.87 | ₹81.52 |
| Change in Assets | -₹89.34 | ₹19.88 | ₹4.33 | -₹21.18 |
| Change in Liabilities | ₹11.20 | ₹3.30 | ₹26.19 | -₹0.65 |
| Change in WC | -₹78.14 | ₹23.18 | ₹30.53 | -₹21.83 |
| Cash flow from Operations | ₹33.83 | ₹105.02 | ₹123.75 | ₹50.41 |
| Cash flow from Investing | ₹0.41 | -₹15.15 | -₹63.53 | -₹32.46 |
| Cash flow from Financing | -₹50.91 | -₹90.86 | -₹41.25 | -₹21.76 |
| Total Cash Flow | -₹16.67 | -₹0.98 | ₹18.97 | -₹3.81 |
| Cash (Start of the year) | ₹13.56 | ₹14.54 | -₹4.49 | -₹0.94 |
| Cash (End of the year) | -₹3.12 | ₹13.56 | ₹14.54 | -₹4.75 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹301.95 | ₹326.35 | ₹410.54 | ₹397.40 |
| Current Assets | ₹320.52 | ₹238.23 | ₹253.32 | ₹315.25 |
| Total Assets | ₹622.47 | ₹564.58 | ₹663.86 | ₹712.65 |
| Current Liabilities | ₹198.43 | ₹160.89 | ₹212.62 | ₹186.66 |
| Net Current Asset | ₹122.09 | ₹77.34 | ₹40.70 | ₹128.59 |
| Non-Current Liabilities | ₹44.08 | ₹89.46 | ₹115.18 | ₹130.02 |
| Equity Capital | ₹379.95 | ₹314.23 | ₹336.06 | ₹395.97 |
| Total Equity & Liabilities | ₹622.47 | ₹564.58 | ₹663.86 | ₹712.65 |
About FERMENTA BIOTECH LTD.
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. It is also engaged in renting and selling properties. Its segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. It has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and others. It provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, and vitamin AD2 premix, among others.
FERMENTA BIOTECH LTD. Financial Highlights
- Revenue: FERMENTA BIOTECH LTD. reported revenue of ₹547.82 crore in FY26 vs ₹481.30 crore in FY25. It showed an increase of 13.82% on a yearly basis.
- Operating Profit: FERMENTA BIOTECH LTD. reported an operating profit of ₹95.86 crore in FY26 vs ₹83.21 crore in FY25. It showed an increase of 15.20% on a year-on-year basis.
- Net Profit: FERMENTA BIOTECH LTD. reported a net profit of ₹70.25 crore in FY26 vs ₹76.40 crore in FY25. It showed a decrease of 8.05% on a yearly basis.
FERMENTA BIOTECH LTD. Quarterly Result Highlights
- FERMENTA BIOTECH LTD. reported revenue of ₹126.64 crore in Mar 2026, compared with ₹140.48 crore in Dec 2025, representing a decrease of 9.85% on a quarter-on-quarter (QoQ) basis.
- FERMENTA BIOTECH LTD. reported an operating profit of ₹26.21 crore in Mar 2026, compared with ₹17.48 crore in Dec 2025, representing an increase of 49.94% on a quarter-on-quarter (QoQ) basis.
- FERMENTA BIOTECH LTD. reported a profit of ₹18.60 crore in Mar 2026, compared with ₹12.02 crore in Dec 2025, reflecting an increase of 54.74% on a QoQ basis.
- The earnings per share (EPS) of FERMENTA BIOTECH LTD. stood at ₹26.35 during Mar 2026.
Similar Stocks
FAQs on FERMENTA BIOTECH LTD. Share Price
What is FERMENTA BIOTECH LTD. share price today?
FERMENTA BIOTECH LTD. share price is ₹343.00 as on 03 Jul, 2026, 15:55 IST.
How has the FERMENTA BIOTECH LTD. share price performed in the past?
In the last 1 year, FERMENTA BIOTECH LTD. delivered a return of 9.87%. The FERMENTA BIOTECH LTD. share price hit a high of ₹375.95 and low of ₹248.85.
How much is the Mutual Fund shareholding in FERMENTA BIOTECH LTD. shares?
The Mutual Fund Shareholding in FERMENTA BIOTECH LTD. was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of FERMENTA BIOTECH LTD. shares ?
The 52-week high and low of FERMENTA BIOTECH LTD. share is ₹375.95 and ₹248.85 as of 03 Jul, 2026.
What is the market cap of FERMENTA BIOTECH LTD.?
The market capitalisation of FERMENTA BIOTECH LTD. is ₹1,032.88 Crores as on 03 Jul, 2026.
What are the stock symbols of FERMENTA BIOTECH LTD.?
The stock symbol of FERMENTA BIOTECH LTD. is FERMENTA on the NSE, 506414 on the BSE, and the ISIN is INE225B01021.
What was yesterday's closing price of FERMENTA BIOTECH LTD. shares ?
FERMENTA BIOTECH LTD. shares closed yesterday at ₹352.00 on NSE & ₹350.95 on BSE
How to buy FERMENTA BIOTECH LTD. shares?
To buy FERMENTA BIOTECH LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy FERMENTA BIOTECH LTD. shares on Holidays?
No, shares of FERMENTA BIOTECH LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell FERMENTA BIOTECH LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of FERMENTA BIOTECH LTD.?
The PE and PB ratio of FERMENTA BIOTECH LTD. is 14.7 and 2.54 respectively, as on 03 Jul, 2026, 15:55 IST.